Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI.
PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells.
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.
Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry.
Present and emerging therapies for multiple sclerosis.
[Optic nerve neuritis].
Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes.
Ongoing clinical trials of TYSABRI
Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
BG-12 in Multiple Sclerosis.
Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations.
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
Postoperative cystoid macular oedema in a patient on fingolimod.
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
PET in Multiple Sclerosis.
The effect of the physiological rest position of the mandible on cerebral blood flow and physical balance: an observational study.
Teaching NeuroImages: Neuromyelitis optica misdiagnosed as spinal cord tumor.
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Validity of Oxygen Uptake Efficiency Slope in patients with multiple sclerosis.
I-BET151 selectively regulates IL-6 production.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Pages
« first
‹ previous
…
502
503
504
505
506
507
508
509
510
…
next ›
last »